NYSE:ALBAlbemarle Stock Price, Forecast & News

$84.31

+4.34 (+5.43 %)

(As of 06/5/2020 04:00 PM ET)

Add

Compare

Today's Range

$80.78

Now: $84.31▼

$84.97

50-Day Range

$57.26

MA: $64.54▼

$78.94

52-Week Range

$48.89

Now: $84.31▼

$99.40

Volume1.95 million shs

Average Volume1.90 million shs

Market Capitalization$8.96 billion

P/E Ratio17.68

Dividend Yield1.93%

Beta1.48

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Consensus Rating
Albemarle has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on 7 buy ratings, 13 hold ratings, and 5 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $74.93, Albemarle has a potential downside of 11.1% from its current price of $84.31.
Amount of Analyst Coverage
Albemarle has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.7 Community Rank

Outperform Votes
Albemarle has received 679 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Albemarle has received 570 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Albemarle has received 54.36% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote “Outperform” if you believe ALB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
Albemarle is a leading dividend payer. It pays a dividend yield of 1.93%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Albemarle has been increasing its dividend for 16 years.
Dividend Coverage
The dividend payout ratio of Albemarle is 25.50 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Albemarle will have a dividend payout ratio of 35.16 % next year. This indicates that Albemarle will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Albemarle insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.07% of the stock of Albemarle is held by insiders.
Percentage Held by Institutions
92.57% of the stock of Albemarle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Albemarle are expected to grow by 29.59% in the coming year, from $3.38 to $4.38 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Albemarle is 17.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of Albemarle is 17.68, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 22.50.
Price to Earnings Growth Ratio
Albemarle has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Albemarle has a P/B Ratio of 2.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.52 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Plastics materials & resins

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

Current SymbolNYSE:ALB

Previous Symbol

CUSIP01265310

CIK915913

Webwww.albemarle.com

Phone980-299-5700

Debt

Debt-to-Equity Ratio0.77

Current Ratio1.81

Quick Ratio1.09

Price-To-Earnings

Trailing P/E Ratio17.68

Forward P/E Ratio24.94

P/E Growth2.71

Sales & Book Value

Annual Sales$3.59 billion

Price / Sales2.50

Cash Flow$8.62 per share

Price / Cash Flow9.78

Book Value$38.61 per share

Price / Book2.18

Profitability

EPS (Most Recent Fiscal Year)$6.04

Net Income$533.23 million

Net Margins14.50%

Return on Equity15.34%

Return on Assets6.88%

Miscellaneous

Employees6,000

Outstanding Shares106,319,000

Market Cap$8.96 billion

Next Earnings Date8/5/2020 (Estimated)

OptionableOptionable

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock been impacted by COVID-19 (Coronavirus)?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALB shares have increased by 20.3% and is now trading at $84.31. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Albemarle?

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 5 sell ratings, 13 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Albemarle.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Albemarle.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Wednesday, May, 6th. The specialty chemicals company reported $1.00 EPS for the quarter, beating the Zacks' consensus estimate of $0.85 by $0.15. The specialty chemicals company had revenue of $738.85 million for the quarter, compared to the consensus estimate of $769.26 million. Albemarle had a net margin of 14.50% and a return on equity of 15.34%. The business's quarterly revenue was down 11.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.23 earnings per share. View Albemarle's earnings history.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, May 5th. Investors of record on Friday, June 12th will be given a dividend of $0.385 per share on Wednesday, July 1st. This represents a $1.54 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date of this dividend is Thursday, June 11th. View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its second quarter 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $700-775 million, compared to the consensus revenue estimate of $775.7 million.

What price target have analysts set for ALB?

25 analysts have issued twelve-month target prices for Albemarle's shares. Their forecasts range from $39.50 to $116.00. On average, they anticipate Albemarle's share price to reach $74.93 in the next twelve months. This suggests that the stock has a possible downside of 11.1%. View analysts' price targets for Albemarle.

Has Albemarle been receiving favorable news coverage?

News stories about ALB stock have trended extremely negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Albemarle earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned press coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutAlbemarle.

Are investors shorting Albemarle?

Albemarle saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 14,710,000 shares, an increase of 7.7% from the April 15th total of 13,660,000 shares. Based on an average daily trading volume, of 2,030,000 shares, the days-to-cover ratio is currently 7.2 days. Currently, 13.9% of the shares of the stock are sold short. View Albemarle's Current Options Chain.

Who are some of Albemarle's key competitors?

Some companies that are related to Albemarle include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), Sensient Technologies (SXT), Stepan (SCL), HB Fuller (FUL) and Innospec (IOSP). View all competitors.

What other stocks do shareholders of Albemarle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Alibaba Group (BABA).

Who are Albemarle's key executives?

Albemarle's management team includes the following people:

Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
Mr. David Ryan, VP of Corp. Strategy & Investor Relations

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include Franklin Resources Inc. (8.26%), BlackRock Inc. (7.64%), State Street Corp (6.57%), Primecap Management Co. CA (5.07%), Baillie Gifford & Co. (4.12%) and Bank of New York Mellon Corp (2.43%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View institutional ownership trends for Albemarle.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Franklin Resources Inc., State Street Corp, Primecap Management Co. CA, Commerzbank Aktiengesellschaft FI, Capital Management Corp VA, Grantham Mayo Van Otterloo & Co. LLC, and Paloma Partners Management Co. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, and Scott Tozier. View insider buying and selling activity for Albemarle.

Which major investors are buying Albemarle stock?

ALB stock was acquired by a variety of institutional investors in the last quarter, including Luminus Management LLC, Marathon Asset Management LLP, KAMES CAPITAL plc, Handelsbanken Fonder AB, Nuveen Asset Management LLC, US Bancorp DE, Scout Investments Inc., and SPF Beheer BV. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris. View insider buying and selling activity for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $84.31.

How big of a company is Albemarle?

Albemarle has a market capitalization of $8.96 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff